
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
MINI REVIEW article
Front. Endocrinol.
Sec. Adrenal Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1510815
This article is part of the Research TopicAdrenal Insufficiency: Diagnostic Approaches, Treatments, and Outcomes Volume IIView all 10 articles
The final, formatted version of the article will be published soon.
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Autoimmune Addison’s Disease (AAD) is by far the most common cause of primaryadrenal insufficiency in developed countries, occurring more commonly in womencompared with men. The condition is associated with a spectrum of disordersaffecting fertility and reproductive health.Premature ovarian insufficiency (POI) is a clinical condition defined by cessation ofmenstrual cycles and menopausal range gonadotrophins before the age of 40 years.This occurs with a prevalence of 1-2% in the general population, but has beenestimated at 6-10% for women with AAD. One registry study demonstrated that onethird of those with AAD who develop POI, do so before the age of thirty. The onset ofPOI precedes or is contemporaneous with the diagnosis of AAD in the majority. Ithas also been demonstrated that women with AAD are more likely to use hormonereplacement therapy.The pathophysiology of POI in this cohort is thought to be primarily throughautoimmune mediated inflammation of the ovarian theca cells. In particular, cross-reacting autoantibodies to steroid-producing cells (StCA) have been identified whichare present in AAD and POI. That said, when women with POI are excluded, fertilityremain significantly reduced.Impaired adrenal androgenesis and resulting sex-hormone deficiency has also beenimplicated in subfertility in AAD. This leads to suboptimal follicular development.This, in turn, may also affect libido. Despite physiological glucocorticoid replacementtherapy, patients with AAD consistently report reduced quality of life compared tomatched controls. These factors may affect fecundity and likelihood of conception.Other autoimmune conditions such as hypothyroidism and type 1 diabetes occur withincreased prevalence in those with AAD. These conditions have been shown toindependently affect reproductive health.This review focuses on the current understanding of the factors and mechanismsimpacting fertility in women with autoimmune Addison’s disease.
Keywords: Addison Disease, Fertility, STCA, PREMATURE OVARIAN INSUFFICIENCY, Autoimmune Diseases, Pregnancy
Received: 13 Oct 2024; Accepted: 21 Feb 2025.
Copyright: © 2025 O'Murchadha and Pazderska. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Liam O'Murchadha, St. James's Hospital, Dublin, Ireland
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Supplementary Material
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.